Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-24 4:15 pm Purchase | 2026-03-20 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 363,280 2.800% | 49,880 (+15.92%) | Filing History |
| 2025-12-22 4:30 pm Purchase | 2025-12-18 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 313,400 5.200% | 410 (+0.13%) | Filing History |
| 2025-09-24 4:30 pm Unchanged | 2025-09-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 312,990 6.200% | 0 (Unchanged) | Filing History |
| 2025-07-01 6:40 pm Sale | 2025-06-27 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 312,990 8.700% | -455 (-0.15%) | Filing History |
| 2025-01-31 9:31 pm Purchase | 2024-12-18 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 313,445 12.400% | 865 (+0.28%) | Filing History |
| 2024-08-23 4:07 pm Purchase | 2024-08-22 | 13D | REVIVA PHARMACEUTICALS HLDGS C RVPH | Parag Saxena | 312,580 16.900% | 312,580 (New Position) | Filing History |